Matches in Nanopublications for { ?s ?p "[In our study, CAGE mRNA was expressed in 39.4% of HCC patients, 73.3% of patients with gastric cancer and 30.8% of patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP281933.RAnbB4DGTgSRp83gIXI_qYNT367h8llKDWWsP0TMzFJ2g130_assertion description "[In our study, CAGE mRNA was expressed in 39.4% of HCC patients, 73.3% of patients with gastric cancer and 30.8% of patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281933.RAnbB4DGTgSRp83gIXI_qYNT367h8llKDWWsP0TMzFJ2g130_provenance.
- NP717991.RAiscu4B8zf_44lNaoPEcsuYcaarzKyxb9w__8fDYhQ8o130_assertion description "[In our study, CAGE mRNA was expressed in 39.4% of HCC patients, 73.3% of patients with gastric cancer and 30.8% of patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717991.RAiscu4B8zf_44lNaoPEcsuYcaarzKyxb9w__8fDYhQ8o130_provenance.
- NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_assertion description "[In our study, CAGE mRNA was expressed in 39.4% of HCC patients, 73.3% of patients with gastric cancer and 30.8% of patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585279.RAHYlXTBnMhdl-wt2ecN2PuCBmq-316OBOKu90hL82RJo130_provenance.